FDA clears Siemens' 2-in-1 medical scanner

Jun 10, 2011

(AP) -- The Food and Drug Administration says it has cleared the first medical imaging device to simultaneously perform two powerful scans used to diagnose a wide variety of diseases and ailments.

The agency says Siemens' Biograph mMR system runs both a positron emission tomography scan, known as a PET scan, and a scan, or MRI scan. The combination is expected to save time and reduce patients' exposure to radiation.

Older devices combine a and computer tomography, which uses high-powered X-ray scans. Siemens' device replaces that technology with the MRI, which does not contain radiation.

MRI scans use magnetic fields to produce detailed images of organs, bones and other internal structures. PET scans work with a radioactive injection to trace blood flow throughout the body.

Explore further: Acne pill benefits outweigh blood clot risk: EU agency

not rated yet
add to favorites email to friend print save as pdf

Related Stories

MRI/PET scanner combo

Mar 07, 2008

Two kinds of body imaging -- positron emission tomography (PET) and magnetic resonance imaging (MRI) -- have been combined for the first time in a single scanner.

New scans improve treatment accuracy

Sep 14, 2006

Australian doctors say they have developed new scans that can that quickly show whether breast cancer cells are responding to therapy.

Recommended for you

FDA has safety concerns on Merck insomnia drug

6 hours ago

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

US adviser on board of firm that sold anthrax drug

12 hours ago

(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...

First influenza vaccine brought to clinical testing

May 17, 2013

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Aspirin not always best treatment for many individuals

May 16, 2013

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

User comments : 0

More news stories

Study shows how bilinguals switch between languages

(Medical Xpress)—Individuals who learn two languages at an early age seem to switch back and forth between separate "sound systems" for each language, according to new research conducted at the University of Arizona.

Study suggests new source of kidneys for transplant

Nearly 20 percent of kidneys that are recovered from deceased donors in the U.S. are refused for transplant due to factors ranging from scarring in small blood vessels of the kidney's filtering units to the organ going too ...

SARS-like virus claims new life in Saudi

A Saudi man who had contracted the coronavirus has died, raising the death toll in the kingdom from the SARS-like virus to 16, the health ministry announced on Monday on its Internet website.

Non-wetting fabric drains sweat

(Phys.org) —Waterproof fabrics that whisk away sweat could be the latest application of microfluidic technology developed by bioengineers at the University of California, Davis.

Lab sets a new record for creating heralded photons

(Phys.org) —Entanglement, by general consensus of physicists, is the weirdest part of quantum science. To say that two particles, A and B, are entangled means that they are actually two parts of an inseparable ...